Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases.

[1]  Hartmut Link,et al.  FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. , 2014, The Lancet. Oncology.

[2]  N. Kokudo,et al.  Favorable Outcome After Repeat Resection for Colorectal Liver Metastases , 2014, Annals of Surgical Oncology.

[3]  M. Makuuchi,et al.  Discrepancy Between Recurrence-Free Survival and Overall Survival in Patients with Resectable Colorectal Liver Metastases: A Potential Surrogate Endpoint for Time to Surgical Failure , 2014, Annals of Surgical Oncology.

[4]  R. Parks,et al.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. , 2013, The Lancet. Oncology.

[5]  J. Tabernero,et al.  Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. , 2013, The New England journal of medicine.

[6]  F. Lehner,et al.  Repeat liver resection for colorectal metastases , 2013, The British journal of surgery.

[7]  R. J. Haas,et al.  Repeat hepatectomy for recurrent colorectal metastases , 2013, The British journal of surgery.

[8]  T. Takayama,et al.  Good Candidates for a Third Liver Resection of Colorectal Metastasis , 2013, World Journal of Surgery.

[9]  L. Capussotti,et al.  A Survival Analysis of the Liver-First Reversed Management of Advanced Simultaneous Colorectal Liver Metastases: A LiverMetSurvey-Based Study , 2012, Annals of surgery.

[10]  M. Takahashi,et al.  Contrast‐enhanced intraoperative ultrasonography using perfluorobutane microbubbles for the enumeration of colorectal liver metastases , 2012, The British journal of surgery.

[11]  M. Makuuchi,et al.  Liver Resection for Multiple Colorectal Liver Metastases with Surgery Up-front Approach: Bi-institutional Analysis of 736 Consecutive Cases , 2012, World Journal of Surgery.

[12]  G. Honda,et al.  A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery , 2012, Journal of hepato-biliary-pancreatic sciences.

[13]  E. Van Cutsem,et al.  Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Makuuchi,et al.  Cohort Study of the Survival Benefit of Resection for Recurrent Hepatic and/or Pulmonary Metastases After Primary Hepatectomy for Colorectal Metastases , 2010, Annals of surgery.

[15]  C. Bokemeyer,et al.  A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  M. Choti,et al.  Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 1669 Patients , 2009, Annals of surgery.

[17]  D. Sargent,et al.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Abdalla.  Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology. , 2009, American journal of surgery.

[19]  R. Labianca,et al.  Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[21]  M. Makuuchi,et al.  Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Bosset,et al.  Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H. Bismuth,et al.  Liver Resection for Colorectal Metastases: The Third Hepatectomy , 2003, Annals of surgery.

[24]  A. Altendorf-Hofmann,et al.  Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.

[25]  R. Greil,et al.  Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. , 2013, The Lancet. Oncology.

[26]  M. Makuuchi,et al.  Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .